UK MHRA/DH still getting heat over PIP
This article was originally published in Clinica
Executive Summary
The UK’s Medicines and Healthcare Products Regulatory Authority (MHRA) and Department of Health (DH) have come under fire again over their handling of the PIP breast implants crisis, prompting criticism over the two bodies’ general modus operandi.